I just feel, watching the stock action, that I have good reason to be concerned about the FDA vote on June 16. Based on the extreme negativity of the FDA on GERNs drug, despite the strong ADCOM, I feel one has to be careful, now that the stock is up 125% from March 14. I will likely hold a small position into the announcement.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.